Skip to main content
. Author manuscript; available in PMC: 2010 Oct 22.
Published in final edited form as: Neurocrit Care. 2009 Aug 28;12(2):274–284. doi: 10.1007/s12028-009-9270-4

Fig. 6.

Fig. 6

Immunological outcome and foot fault performance. A Th1(+) response to MBP in spleen did not affect performance on the foot fault test after MCAO (a). Animals evidencing a Th1(+) response to NSE (b) or PLP (c) in spleen made more errors on the foot fault test 1 month after MCAO. * P < 0.05, ** P < 0.01 using the t-test